Janssen Exec On Speeding Earlier Myeloma Interventions To Market With Key Biomarker

 
• By Eleanor Malone
  
PS1806_Tractor_115709221_1200.jpg
Janssen hopes regulators will help speed its plow with new myeloma surrogate endpoint
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D